FDA Import Refusal 1FX-3020014-0/30002/1 — MEPHA PHARMA
The FDA refused shipment 1FX-3020014-0/30002/1 from MEPHA PHARMA (Poland) on June 8, 2026. The refused product falls under Drugs and Biologics — DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- June 8, 2026
- Country
- Poland
- Product Category
- Drugs and Biologics
- Product Code
- 62GAB90 DICLOFENAC POTASSIUM (ANTI-INFLAMMATORY)
- Charges
- 75